Lin Xiaoyuan, Sha Zhou, Zhang Chunlin, Adler Julia M, Vidal Ricardo Martin, Langner Christine, Fu Beibei, Xiong Yan, Tan Meng, Jiang Chen, Zeng Hao, Zhang Xiaokai, Li Qian, Yan Jingmin, Lu Xiaoxue, Wang Shiwei, Mao Xuhu, Kunec Dusan, Trimpert Jakob, Wu Haibo, Zou Quanming, Zhu Zhenglin
Department of Clinical Microbiology and Immunology, College of Pharmacy and Medical Laboratory, Army Medical University (Third Military Medical University), Chongqing, China.
Institut für Virologie, Freie Universität Berlin, Robert-von-Ostertag-Straße, Berlin, Germany.
Nat Commun. 2025 Jul 29;16(1):6951. doi: 10.1038/s41467-025-62300-0.
How SARS-CoV-2 Omicron evolved remains obscure. T492I, an Omicron-specific mutation encountered in SARS-CoV-2 nonstructural protein 4 (NSP4), enhances viral replication and alters nonstructural protein cleavage, inferring potentials to drive evolution. Through evolve-and-resequence experiments of SARS-CoV-2 wild-type (hCoV-19/USA/WA-CDC-02982585-001/2020, A) and Delta strains (B.1.617) with or without T492I, this study demonstrates that the NSP4 mutation T492I confers accelerated phenotypic adaption and a predisposition to the emergence of SARS-CoV-2 Omicron-like variants. The T492I-driven evolution results in accelerated enhancement in viral replication, infectivity, immune evasion capacity, receptor-binding affinity and potential for cross-species transmission. Aside from elevated mutation rates and impact on deaminases, positive epistasis between T492I and adaptive mutations could potentially mechanistically facilitate the shifts in mutation spectra and indirectly determines the Omicron-predisposing evolution. These suggest a potentially important role of the driver mutation T492I in the evolution of SARS-CoV-2 Omicron variants. Our findings highlight the existence and importance of mutation-driven predisposition in viral evolution.
严重急性呼吸综合征冠状病毒2(SARS-CoV-2)奥密克戎变异株的进化过程仍不清楚。T492I是在SARS-CoV-2非结构蛋白4(NSP4)中发现的一种奥密克戎特异性突变,它能增强病毒复制并改变非结构蛋白的切割,这意味着它具有推动进化的潜力。通过对带有或不带有T492I的SARS-CoV-2野生型毒株(hCoV-19/USA/WA-CDC-02982585-001/2020,A)和德尔塔毒株(B.1.617)进行进化与重测序实验,本研究表明,NSP4突变T492I能加速表型适应,并使SARS-CoV-2奥密克戎样变异株更易出现。由T492I驱动的进化导致病毒复制、传染性、免疫逃逸能力、受体结合亲和力和跨物种传播潜力加速增强。除了提高突变率和对脱氨酶的影响外,T492I与适应性突变之间的正向上位效应可能在机制上促进了突变谱的转变,并间接决定了奥密克戎倾向的进化。这些结果表明驱动突变T492I在SARS-CoV-2奥密克戎变异株的进化中可能发挥重要作用。我们的研究结果突出了突变驱动的倾向在病毒进化中的存在及其重要性。